Lippold Cassiopia L, Kalarn Sachin P, Swamy Ramya N, Patel Ami M
Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Opthomology and Visual Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Hemodial Int. 2019 Jul;23(3):E72-E77. doi: 10.1111/hdi.12718. Epub 2019 Feb 20.
It has been shown that patients with end-stage renal disease (ESRD) have an increased risk for changes in intraocular pressure during hemodialysis, or ocular dialysis disequilibrium which can cause pain or discomfort during treatment and lead to decreased vision over time. This is a case of an elderly male with ESRD who was having headaches, nausea, and eye pain during hemodialysis due to increased intraocular pressures. Using a higher sodium prescription resolved his symptoms and normalized his intraocular pressures. This case illustrates that modification in dialysate tonicity can decrease changes in intraocular pressures while patients are on hemodialysis, a vision saving consideration for patients.
研究表明,终末期肾病(ESRD)患者在血液透析期间眼压变化的风险增加,即发生眼透析失衡,这可能在治疗期间引起疼痛或不适,并随着时间的推移导致视力下降。这是一例患有ESRD的老年男性病例,他在血液透析期间因眼压升高出现头痛、恶心和眼痛。使用较高的钠处方缓解了他的症状并使眼压恢复正常。该病例表明,在患者进行血液透析时,调整透析液张力可降低眼压变化,这是一项保护患者视力的考虑因素。